Joseph A. Costa, D.O.

Joseph A. Costa D.O.

Professor & Assistant Dean for Clinical Informatics; Program Director, Urology Residency

Department: Department of Urology
Business Phone: (904) 244-7340
Business Email: Joseph.costa@jax.ufl.edu

About Joseph A. Costa

Dr. Costa is an internationally renowned reconstructive urologist specializing in pelvic urologic disorders. He is specially trained in treating patients with spinal cord injuries, multiple sclerosis and other neurological conditions.

Board Certifications

  • Urology
  • Female Pelvic Medicine and Reconstructive Surgery

Clinical Profile

Specialties
  • Neurourology & Reconstructive Surgery
  • Urology
Interests
  • Clinical Special Interests: Male and female incontinence; reconstructive surgery; female pelvic organ prolapse (cystocele, rectocele, uterine prolapse); male urethral stricture disease; spinal cord injury and neurourology; multiple sclerosis; neuropathic voiding dysfunction; transurethral needle ablation of the prostate; urodynamic services

Publications

2023
Predictors of readmission and impact of same-day discharge in holmium laser enucleation of the prostate.
Prostate international.11(1):20-26[DOI] 10.1016/j.prnil.2022.07.003.[PMID] 36910904.
2022
Estimated Glomerular Filtration Rate Predicts Complications Following Artificial Urinary Sphincter Surgery.
Urology.168():208-215[DOI] 10.1016/j.urology.2022.06.019.[PMID] 35779711.
2021
An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
Journal of endourology.35(4):409-416[DOI] 10.1089/end.2020.0739.[PMID] 32962442.
2021
Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.
Journal of robotic surgery.15(3):321-333[DOI] 10.1007/s11701-020-01174-4.[PMID] 33222043.
2021
Pathology grade influences competing mortality risks in elderly men with prostate cancer.
Urologic oncology.39(8):493.e1-493.e7[DOI] 10.1016/j.urolonc.2020.12.004.[PMID] 33353870.
2020
A Systematic Review and Meta-Analysis of Methods Used to Reduce Infectious Complications Following Transrectal Prostate Biopsy.
Urology.144():21-27[DOI] 10.1016/j.urology.2020.06.005.[PMID] 32569659.
2020
Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis.
Urologic oncology.38(11):826-834[DOI] 10.1016/j.urolonc.2020.03.022.[PMID] 32605736.
2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer.
Cancer investigation.37(2):85-89[DOI] 10.1080/07357907.2019.1565766.[PMID] 30836776.
2018
Bilateral distal ureteral transection in the setting of blunt trauma.
Trauma surgery & acute care open.3(1):e000175-[DOI] 10.1136/tsaco-2018-000175.[PMID] 30023435.
2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement.
American journal of clinical oncology.41(12):1243-1245[DOI] 10.1097/COC.0000000000000454.[PMID] 29727310.
2016
Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer.
International journal of particle therapy.3(1):21-26[DOI] 10.14338/IJPT-16-00007.1.[PMID] 31772972.
2016
Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer.
International journal of particle therapy.2(4):518-524[DOI] 10.14338/IJPT-15-00034.1.[PMID] 30079368.
2015
Hemorrhagic radiation cystitis.
American journal of clinical oncology.38(3):331-6[DOI] 10.1097/COC.0000000000000016.[PMID] 24322335.
2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.
International journal of radiation oncology, biology, physics.88(3):596-602[DOI] 10.1016/j.ijrobp.2013.11.007.[PMID] 24521677.
2014
Warty Condylomatous Squamous Cell Carcinoma of the Penis in a 19-Year-Old.
Urology case reports.2(3):79-81[DOI] 10.1016/j.eucr.2014.03.002.[PMID] 26955552.
2013
Catheter length preference in wheelchair-using men who perform routine clean intermittent catheterization.
Spinal cord.51(10):772-5[DOI] 10.1038/sc.2013.76.[PMID] 23896665.
2013
Early Gastrointestinal Toxicity Outcomes From a Prospective Trial of Accelerated Hypofractionation With Proton Therapy for Prostate Cancer
International Journal of Radiation Oncology Biology Physics.87():S154-[DOI] .[PMID] .
2013
Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer On 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics.87():S155-[DOI] .[PMID] .
2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.
Acta oncologica (Stockholm, Sweden).52(3):492-7[DOI] 10.3109/0284186X.2013.767983.[PMID] 23477360.
2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials.
Acta oncologica (Stockholm, Sweden).52(3):463-9[DOI] 10.3109/0284186X.2013.764467.[PMID] 23477359.
2012
Catheter Length Preference in Wheelchair Bound Male Patients Who Perform Clean Intermittent Catheterization.
Neurourology and Urodynamics.31():773-774[DOI] .[PMID] .
2012
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer.
International journal of radiation oncology, biology, physics.82(1):213-21[DOI] 10.1016/j.ijrobp.2010.09.024.[PMID] 21093164.
2012
Early Patterns of Failure in a Prospective Trial of Concomitant Docetaxel and Proton Therapy for High-Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics.84():S92-[DOI] .[PMID] .
2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.
Cancer.118(18):4619-26[DOI] 10.1002/cncr.27398.[PMID] 22253020.
2012
Hypofractionated Proton Radiation Therapy for Low- And, Intermediate-Risk Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression
International Journal of Radiation Oncology Biology Physics.84():S375-[DOI] .[PMID] .
2012
Incidence of New Onset Pelvic Organ Prolapse After Repair of Other Segment in a Prospective Longitudinal Database. Topic: Reconstructive Surgery, Pelvic Organ Prolapse Or Urogenitcal Prolapse
Neurourology and Urodynamics.31():856-[DOI] .[PMID] .
2012
Patient-Reported Quality of Life Following Treatment of Prostate Cancer With Proton Therapy
International Journal of Radiation Oncology Biology Physics.84():S213-[DOI] .[PMID] .
2012
Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression.
International journal of radiation oncology, biology, physics.82(3):1222-6[DOI] 10.1016/j.ijrobp.2010.12.025.[PMID] 21570206.
2012
Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients.
Journal of endourology.26(5):467-8[DOI] 10.1089/end.2011.0558.[PMID] 22141439.
2011
Patient-Reported Sexual Function Following Proton Therapy for Prostate Cancer in Men Age <= 60 Years
International Journal of Radiation Oncology Biology Physics.81():S414-[DOI] .[PMID] .
2011
Percutaneous intervention of large bladder calculi in neuropathic voiding dysfunction.
International braz j urol : official journal of the Brazilian Society of Urology.37(5):636-41[DOI] .[PMID] 22099276.
2010
Early Outcomes Following Proton Therapy for Prostate Cancer in Men 55 Years Old and Younger
International Journal of Radiation Oncology Biology Physics.78():S373-S374[DOI] .[PMID] .
2010
Risk of Hip and Femoral Neck Fractures Following Proton Therapy for Prostate Cancer
International Journal of Radiation Oncology Biology Physics.78():S192-S193[DOI] .[PMID] .
2006
Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound guided biopsy of the prostate: a prospective, randomized, controlled trial.
The Journal of urology.176(4 Pt 1):1372-5[DOI] .[PMID] 16952635.

Office Information

Academic Office
3rd Floor, Faculty Clinic
653 West 8th Street, FC12
Jacksonville, FL 32209
(904) 244-7340
Joseph.costa@jax.ufl.edu
Senior Medical Secretary
Melanie Prescott
(904) 244-7340
Melanie.Prescott@jax.ufl.edu
GME Office
3rd Floor, Faculty Clinic
653 West 8th Street
Jacksonville, FL 32209
Phone: (904) 244-7281
Fax: (904) 244-7422
Joseph.costa@jax.ufl.edu
Program Coordinator
Shahriar Koochekpour
(904) 244-7281
Shahriar.koochekpour@jax.ufl.edu

Education

Medical Degree
1991 · College of Osteopathic Medicine of The Pacific, Pomona, CA, USA
Urology Residency
1999 · Naval Medical Center (Portsmouth), Portsmouth, VA, USA
Neurourology & Reconstructive Surgery Fellowship
2000 · University of Iowa Hospitals and Clinics, Iowa City, IA, USA